FOLH1 and neoplasm: SPECT/CT studies visualized the described tissue distribution profile of [177Lu]Lu-PSMA-TB-01 with a negligible accumulation of activity in the PC-3 flu tumor xenografts, which confirmed the PSMA-specific tumor uptake of the novel radioligand.